The most comprehensive rheumatoid arthritis panel - 6 biomarkers for accurate and early diagnosis.
labcorp.com/tests/520314/r…

Getting a diagnosis can be hard for patients who are seronegative. The SeroNeg RAdx4 panel for RA improves diagnosis of established or early RA, especially in individuals who are seronegative for RF and Anti-CCP, and may also help predict disease severity.
labcorp.com/tests/520305/s…

Are you managing chronic joint pain with over-the-counter pain medications? Get to the cause of your joint pain with the 14-3-3η blood test for Rheumatoid Arthritis.
augurex.com/are-you-at-ris…

The RheumAssure® panel detects RA earlier than traditional blood tests by combining 14-3-3η (eta) protein with RF and anti-CCP. Used together, these markers can diagnose established RA with a sensitivity of 88-96% and early RA with a sensitivity of 78-92%.
labcorp.com/tests/504509/r…

Thrilled to announce a $5 million investment from Pacific Economic Development Canada! This incredible support will fast-track the launch of our Ankylosing Spondylitis Blood Test, propelling our global expansion as we keep innovating.
bit.ly/pacific-econom…

The 14-3-3η (eta) blood test can detect Rheumatoid Arthritis (RA) earlier, identifying 21%-67% of RA patients who test negative in traditional RF and anti-CCP blood tests.
labcorp.com/tests/504550/1…

Confidently evaluate RA with industry-leading sensitivity. The RAdx6 Profile combines two traditional markers with four novel markers to enhance diagnosis in early or established RA and determine disease severity for better patient outcomes.
labcorp.com/tests/520304/r…

Seronegative rheumatoid arthritis (RA) can go overlooked. The RheumAssure® panel combines traditional RF and anti-CCP markers with 14-3-3η (eta) to accurately diagnose early and established RA even when negative for RF and anti-CCP. labcorp.com/tests/504509/r…

High levels of 14-3-3η can indicate a poor prognosis and mark faster disease progression. For higher-risk patients, tight management and escalated first-line treatment can lead to achieving remission. labcorp.com/tests/504550/1…

RheumAssure® panel detects RA earlier than traditional blood tests by combining 14-3-3η (eta) protein with RF and anti-CCP. Used together, these markers can diagnose established RA with a sensitivity of 88-96% and early RA with a sensitivity of 78-92%. labcorp.com/tests/504509/r…

Are you managing chronic joint pain with over-the-counter pain medications? Get to the cause of your joint pain with the 14-3-3η blood test for Rheumatoid Arthritis. augurex.com/are-you-at-ris…

Confidently evaluate RA with industry-leading sensitivity. The RAdx6 Profile combines two traditional markers with four novel markers to enhance diagnosis in early or established RA and determine disease severity for better patient outcomes. labcorp.com/tests/520304/r…

Do you have persistent joint pain? Act quickly before joint damage occurs. Find out if you're at risk of Rheumatoid Arthritis.
augurex.com/are-you-at-ris…

The 14-3-3η (eta) blood test can detect Rheumatoid Arthritis (RA) earlier, identifying 21%-67% of RA patients who test negative in traditional RF and anti-CCP blood tests.
augurex.com/prevent-perman…

Is persistent joint pain leading you to rely on over-the-counter pain medications? Uncover the root of your discomfort with the 14-3-3η blood test for Rheumatoid Arthritis.
augurex.com/are-you-at-ris…

Make informed decisions on treatment course with accurate diagnosis and monitoring of RA with 14-3-3η (eta).
augurex.com/prevent-perman…

New markers are available to better identify patients with rheumatoid arthritis. RAdx6 Profile combines traditional and novel markers to diagnose early or established RA (even seronegative) and stratify patients for risk of radiographic progression to optimize treatment outcomes.

Seronegative rheumatoid arthritis (RA) can go overlooked. The RheumAssure® panel combines traditional RF and anti-CCP markers with 14-3-3η (eta) to accurately diagnose early and established RA even when negative for RF and anti-CCP.
labcorp.com/tests/504509/r…

High levels of 14-3-3η can indicate a poor prognosis and mark faster disease progression. For higher-risk patients, tight management and escalated first-line treatment can lead to achieving remission.
augurex.com/prevent-perman…

RheumAssure® panel detects RA earlier than traditional blood tests by combining 14-3-3η (eta) protein with RF and anti-CCP. Used together, these markers can diagnose established RA with a sensitivity of 88-96% and early RA with a sensitivity of 78-92%.
labcorp.com/tests/504509/r…